Trends in hospitalizations and mortality from asthma in costa rica over a 12- to 15-year period

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 1, 2014, Pages 85-90

  Soto Martínez, Manuel ^a   Avila, Lydiana ^a   Soto, Natalia ^a   Chaves, Albin ^b   Celedón, Juan C ^c   Soto Quiros, Manuel E ^a  

^a HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^b CAJA COSTARRICENSE DE SEGURO SOCIAL   (Costa Rica)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Asthma; Costa Rica; Hospitalizations; Mortality

Indexed keywords

BECLOMETASONE; CORTICOSTEROID; FORMOTEROL; MONTELUKAST;

ADULT; AGE; ARTICLE; ASTHMA; CHILD; CORTICOSTEROID THERAPY; COSTA RICA; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRESCRIPTION; TREND STUDY;

ASTHMA; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; COPD; COSTA RICA; HNN; HOSPITAL NACIONAL DE NIÑOS; HOSPITALIZATIONS; ICS; INHALED CORTICOSTEROIDS; MORTALITY; NAP; NATIONAL ASTHMA PROGRAM;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; CHILD; COSTA RICA; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; GLUCOCORTICOIDS; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HOSPITALIZATION; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; SEX DISTRIBUTION; TIME FACTORS; YOUNG ADULT;

EID: 84891664920     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.09.010     Document Type: Article

References (16)

1. Celedon J.C., Soto-Quiros M.E., Silverman E.K., Hanson L., Weiss S.T. Risk factors for childhood asthma in Costa Rica. Chest 2001, 120:785-790.
2. Soto-Quiros M.E., Soto-Martinez M., Hanson L.A. Epidemiological studies of the very high prevalence of asthma and related symptoms among school children in Costa Rica from 1989 to 1998. Pediatr Allergy Immunol 2002, 13:342-349.
3. Asher M.I., Montefort S., Bjorksten B., Lai C.K., Strachan D.P., Weiland S.K., et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006, 368:733-743.
4. Hunninghake G.M., Soto-Quiros M.E., Lasky-Su J., Avila L., Ly N.P., Liang C., et al. Dust mite exposure modifies the effect of functional IL10 polymorphisms on allergy and asthma exacerbations. J Allergy Clin Immunol 2008, 122:93-98. 98.e1-5.
5. Soto-Quiros M. Guia de Diagnostico y Tratamiento del Niño Asmatico. Guia Pediatrica Basica de Diagnostico y Tratamiento I Infecciones respiratorias Agudas II Asma BronquialApoyo a los Recursos Humanos en el Plan de Supervivencia Infantil PASCAP OPS/OMS 1988.
6. Donahue J.G., Weiss S.T., Livingston J.M., Goetsch M.A., Greineder D.K., Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997, 277:887-891.
7. International Monetary Fund. Costa Rica and the IMF. Available from:. Accessed September 12, 2013. http://www.imf.org/external/country/CRI/index.htm.
8. Cloutier M.M., Hall C.B., Wakefield D.B., Bailit H. Use of asthma guidelines by primary care providers to reduce hospitalizations and emergency department visits in poor, minority, urban children. J Pediatr 2005, 146:591-597.
9. Cloutier M.M., Grosse S.D., Wakefield D.B., Nurmagambetov T.A., Brown C.M. The economic impact of an urban asthma management program. Am J Manag Care 2009, 15:345-351.
10. Harju T., Keistinen T., Tuuponen T., Kivela S.L. Hospital admissions of asthmatics by age and sex. Allergy 1996, 51:693-696.
11. Haahtela T., Klaukka T., Koskela K., Erhola M., Laitinen L.A. Working Group of the Asthma Programme in Finland. Asthma programme in Finland: a community problem needs community solutions. Thorax 2001, 56:806-814.
12. Haahtela T., Tuomisto L.E., Pietinalho A., Klaukka T., Erhola M., Kaila M., et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006, 61:663-670.
13. Hunninghake G.M., Soto-Quiros M.E., Avila L., Su J., Murphy A., Demeo D.L., et al. Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood. J Allergy Clin Immunol 2007, 120:84-90.
14. Neffen H., Baena-Cagnani C.E., Malka S., Sole D., Sepulveda R., Caraballo L., et al. Asthma mortality in Latin America. J Investig Allergol Clin Immunol 1997, 7:249-253.
15. Suissa S., Ernst P., Benayoun S., Baltzan M., Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000, 343:332-336.
16. Suissa S., Ernst P. Use of anti-inflammatory therapy and asthma mortality in Japan. Eur Respir J 2003, 21:101-104.